REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Phosphorus Containing Other Than Solely As Part Of An Inorganic Ion In An Addition Salt Doai > Nitrogen Containing Hetero Ring > Hetero Ring Is Five-membered Hetero Ring Is Five-memberedHetero Ring Is Five-membered patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.12/14/06 - 20060281715 - Phosphates of secondary alcohols According to the invention, there is provided a phosphate derivative of a compound having a secondary hydroxy group. The compound having a secondary hydroxyl group may, for example, be chosen from pravastatin, atorvastatin venlafaxine, their derivatives and mixtures thereof. ... 11/30/06 - 20060270633 - Crystalline form of fosinopril calcium Novel crystalline form of fosinopril calcium, process for its preparation, pharmaceutical compositions and use thereof in therapy. ... 07/27/06 - 20060166939 - Fertilizer-compatible composition This invention relates to pesticidal compositions compatible with liquid fertilizers and methods of use thereof. ... 07/20/06 - 20060160772 - Process for manufacture of fosinopril sodium The present invention discloses a process for the synthesis of fosinopril as a single desired isomer of high purity in two steps comprising of (a) preparation of fosinopril as a mixture of four diastereomers and (b) separation of the desired isomer from the mixture through formation of alkali metal salts ... 06/22/06 - 20060135482 - Use of fosinopril to reduce cardiovascular events in disalysis patients The invention relates to the use of fosinopril or a pharmaceutically acceptable salt thereof, to reduce the risk of occurrence of a cardiovascular event in dialysis patients, in particular blood dialysis patients, especially patients presenting left-ventricular hypertrophy. ... 05/25/06 - 20060111325 - Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use Acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphonous acid, 3-aminopropylphosphinic acid, and analogs thereof, pharmaceutical compositions comprising acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphonous acid, 3-aminopropylphosphinic acid, and analogs thereof, methods of making prodrugs of 3-aminopropylphosphonous acid, 3-aminopropylphosphinic acid, and analogs thereof, methods of using prodrugs of 3-aminopropylphosphonous acid, 3-aminopropylphosphinic acid, and analogs thereof and ... 01/26/06 - 20060019930 - Treatment and prevention of tissue damage An agent for use in medicine, which agent comprises a plurality of ligands covalently co-linked so as to form a complex with a plurality of C-reactive protein (CRP) molecules in the presence thereof, wherein (i) at least two of the ligands are the same or different and are capable of ... 11/24/05 - 20050261252 - Lpa receptor agonists and antagonists and methods of use The present invention relates to compounds according to formula (I) as disclosed herein as well as pharmaceutical compositions which include those compounds. Also disclosed are methods of using such compounds, which have activity as agonists or as antagonists of LPA receptors; such methods including inhibiting LPA activity on an LPA ... 08/25/05 - 20050187194 - Preventive agents for diabetes mellitus The present invention relates to a pharmaceutical composition containing an FBPase inhibitor as an active ingredient, which is a preventative agent for diabetes mellitus, diabetic complications, hyperlipidemia, hypertension, arteriosclerosis, macroangiopathy, and the like and a therapeutic agent for IGT, and which can safely and easily be administered for a long ... 06/02/05 - 20050119231 - Quinolone antibacterial agents Compounds of formula I and methods for their preparation are disclosed. Further disclosed are methods of making biologically active compounds of formula I as well as pharmaceutically acceptable compositions comprising compounds of formula I. Compounds of formula I as disclosed herein can be used in a variety of applications including ... ### FreshPatents.com Support |